{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:25:09Z","timestamp":1778541909727,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To report a case of recurrent bilateral combined branch retinal vein occlusion (BRVO) and branch retinal artery occlusion (BRAO) with paracentral acute middle maculopathy (PAMM) as the first manifestation of lung adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>A 54-year-old male with a history of inferonasal BRVO in the left eye (LE), was referred to our department for blurred vision in the LE. On examination, best-corrected visual acuity was 20\/20 in the right eye (RE) and 20\/25 in the LE. Fundus examination showed tortuosity and dilatation of the inferotemporal branch vein, cotton-wool spots, retinal hemorrhages, and areas of retinal whitening in both eyes corresponding to a BRVO associated with BRAO and PAMM. A few months later, the patient complained of blurred vision in the RE. Examination revealed a superior temporal BRVO and BRAO. An exhaustive work-up was performed. Results showed a high level of antiphospholipid antibodies. Chest scan showed the presence of a pulmonary mass related to lung adenocarcinoma. The patient underwent a surgical removal of the lung tumoral mass and chemotherapy. The level of antiphospholipid antibodies was back to normal and no recurrence of ocular symptoms was noted after a follow-up of one year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The association between retinal vascular occlusions and systemic carcinomas is rare. Malignant tumors may induce a hypercoagulation state and an increased risk of thromboembolic complications including branch retinal vascular occlusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00574-1","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:26:57Z","timestamp":1774952817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent combined branch retinal vein and branch retinal artery occlusion associated with PAMM as the first manifestation of lung adenocarcinoma: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Eya","family":"Essassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wijden","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymen","family":"Abdeljelil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek","family":"Kechida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Khochtali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bechir","family":"Jelliti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moncef","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"9","key":"574_CR1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1055\/a-2097-0938","volume":"240","author":"N Feltgen","year":"2023","unstructured":"Feltgen N, Agostini H (2023) Retinal Vascular Occlusion and Underlying Generalized Vascular Diseases. Klin Monbl Augenheilkd 240(9):1071\u20131076","journal-title":"Klin Monbl Augenheilkd"},{"issue":"10","key":"574_CR2","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.4103\/ijo.IJO_2116_19","volume":"68","author":"V Raval","year":"2020","unstructured":"Raval V, Nayak S, Saldanha M, Jalali S, Pappuru RR, Narayanan R et al (2020) Combined retinal vascular occlusion: Demography, clinical features, visual outcome, systemic co-morbidities, and literature review. Indian J Ophthalmol 68(10):2136\u20132142","journal-title":"Indian J Ophthalmol"},{"key":"574_CR3","doi-asserted-by":"publisher","first-page":"109207","DOI":"10.1016\/j.thromres.2024.109207","volume":"244","author":"P Ortega-Toledo","year":"2024","unstructured":"Ortega-Toledo P, Rodr\u00edguez-Gaspar M\u00c1, Barrios-Padilla IC, Mantol\u00e1n-Sarmiento C, de La Paz-Estrello AM, Fern\u00e1ndez-Alonso P et al (2024) Retinal vascular events and relationship to CANCER development. Thromb Res 244:109207","journal-title":"Thromb Res"},{"issue":"8","key":"574_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jfo.2019.12.011","volume":"43","author":"A Rhizlane","year":"2020","unstructured":"Rhizlane A, Lakrimi S, Afkir S, Oujidi W, Siham C, Maadan A et al (2020) [Bilateral central retinal vein occlusion as presenting sign of lung cancer]. J Fr Ophtalmol 43(8):805\u2013808","journal-title":"J Fr Ophtalmol"},{"issue":"6","key":"574_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0002-9394(03)00716-5","volume":"136","author":"SD Adrean","year":"2003","unstructured":"Adrean SD, Schwab IR (2003) Central retinal vein occlusion and renal cell carcinoma. Am J Ophthalmol 136(6):1185\u20131186","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"574_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.oftal.2012.06.007","volume":"88","author":"VM Asensio-S\u00e1nchez","year":"2013","unstructured":"Asensio-S\u00e1nchez VM, Hernaez-Ortega MC, Castresana-Jauregui I (2013) [Central retinal vein occlusion as the first symptom of ovarian cancer]. Arch Soc Esp Oftalmol 88(12):482\u2013484","journal-title":"Arch Soc Esp Oftalmol"},{"key":"574_CR7","first-page":"Doc04","volume":"9","author":"VG Madanagopalan","year":"2019","unstructured":"Madanagopalan VG, Paneer Selvam V, Sarath Sivan NV, Govindaraju NV (2019) Central retinal vein occlusion in a patient with breast carcinoma. GMS Ophthalmol Cases 9:Doc04","journal-title":"GMS Ophthalmol Cases"},{"issue":"11","key":"574_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archopht.1993.01090110025011","volume":"111","author":"ER Schaible","year":"1993","unstructured":"Schaible ER, Golnik KC (1993) Combined obstruction of the central retinal artery and vein associated with meningeal carcinomatosis. Arch Ophthalmol 111(11):1467\u20131468","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"574_CR9","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.jfo.2021.08.019","volume":"45","author":"H Zgolli","year":"2022","unstructured":"Zgolli H, Mabrouk S, Abdaoui M, Zeghal I, Fekih O, Nacef L (2022) Unusual case of combined central retinal artery and vein occlusion in a patient with acute lymphoblastic leukemia. J Fr Ophtalmol 45(4):e195\u2013e197","journal-title":"J Fr Ophtalmol"},{"issue":"3","key":"574_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/ijo.IJO_340_16","volume":"65","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, Pan U (2017) Combined branch retinal vein and branch retinal artery occlusion - clinical features, systemic associations, and outcomes. Indian J Ophthalmol 65(3):238\u2013241","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"574_CR11","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1055\/a-1701-2809","volume":"122","author":"D Green","year":"2022","unstructured":"Green D (2022) Pathophysiology of Antiphospholipid Syndrome. Thromb Haemost 122(7):1085\u20131095","journal-title":"Thromb Haemost"},{"issue":"5","key":"574_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.semarthrit.2005.07.003","volume":"35","author":"JA G\u00f3mez-Puerta","year":"2006","unstructured":"G\u00f3mez-Puerta JA, Cervera R, Espinosa G, Aguil\u00f3 S, Bucciarelli S, Ramos-Casals M et al (2006) Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 35(5):322\u2013332","journal-title":"Semin Arthritis Rheum"},{"issue":"SI","key":"574_CR13","doi-asserted-by":"publisher","first-page":"SI24","DOI":"10.1093\/rheumatology\/kead571","volume":"63","author":"P Gaspar","year":"2024","unstructured":"Gaspar P, Sciascia S, Tektonidou MG (2024) Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. Rheumatology (Oxford) 63(SI):SI24\u201336","journal-title":"Rheumatology (Oxford)"},{"key":"574_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.thromres.2020.04.005","volume":"190","author":"JL Hern\u00e1ndez","year":"2020","unstructured":"Hern\u00e1ndez JL, Sanl\u00e9s I, P\u00e9rez-Montes R, Mart\u00ednez-Taboada VM, Olmos JM, Salm\u00f3n Z et al (2020) Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion. Thromb Res 190:63\u201368","journal-title":"Thromb Res"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00574-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:59:53Z","timestamp":1778540393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00574-1","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Oral informed consent was obtained from the participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the patient\u2019s clinical details and images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}